Morgan Stanley’s iShares iBonds Dec 2028 Term Corporate ETF IBDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$122M Buy
4,818,723
+167,067
+4% +$4.22M 0.01% 1409
2026
Q1
$118M Buy
4,651,656
+61,684
+1% +$1.57M 0.01% 1296
2025
Q4
$117M Buy
4,589,972
+216,028
+5% +$5.5M 0.01% 1314
2025
Q3
$112M Buy
4,373,944
+325,179
+8% +$8.26M 0.01% 1314
2025
Q2
$103M Buy
4,048,765
+307,887
+8% +$7.76M 0.01% 1298
2025
Q1
$94.5M Buy
3,740,878
+190,901
+5% +$4.78M 0.01% 1290
2024
Q4
$88.4M Buy
3,549,977
+484,408
+16% +$12.2M 0.01% 1347
2024
Q3
$78.3M Buy
3,065,569
+288,330
+10% +$7.27M 0.01% 1432
2024
Q2
$68.8M Buy
2,777,239
+368,374
+15% +$9.08M 0.01% 1450
2024
Q1
$60M Buy
2,408,865
+259,688
+12% +$6.46M ﹤0.01% 1595
2023
Q4
$53.9M Buy
2,149,177
+303,385
+16% +$7.37M ﹤0.01% 1651
2023
Q3
$44.4M Buy
1,845,792
+633,224
+52% +$15.4M ﹤0.01% 1689
2023
Q2
$29.7M Buy
1,212,568
+383,288
+46% +$9.49M ﹤0.01% 2076
2023
Q1
$20.7M Buy
829,280
+203,954
+33% +$5.04M ﹤0.01% 2379
2022
Q4
$15.2M Buy
625,326
+147,973
+31% +$3.57M ﹤0.01% 2617
2022
Q3
$11.4M Buy
477,353
+37,402
+9% +$933K ﹤0.01% 2812
2022
Q2
$11M Buy
439,951
+322,156
+273% +$8.16M ﹤0.01% 2980
2022
Q1
$3.1M Sell
117,795
-158,769
-57% -$4.32M ﹤0.01% 4167
2021
Q4
$7.83M Buy
276,564
+31,365
+13% +$892K ﹤0.01% 3220
2021
Q3
$7.03M Buy
245,199
+31,609
+15% +$916K ﹤0.01% 3326
2021
Q2
$6.17M Buy
213,590
+85,895
+67% +$2.46M ﹤0.01% 3564
2021
Q1
$3.62M Buy
127,695
+45,018
+54% +$1.3M ﹤0.01% 3746
2020
Q4
$2.44M Buy
82,677
+7,091
+9% +$207K ﹤0.01% 3983
2020
Q3
$2.2M Buy
75,586
+1,810
+2% +$53K ﹤0.01% 3572
2020
Q2
$2.13M Buy
73,776
+34,686
+89% +$964K ﹤0.01% 3534
2020
Q1
$1.03M Buy
39,090
+15,520
+66% +$429K ﹤0.01% 3931
2019
Q4
$654K Buy
23,570
+6,020
+34% +$167K ﹤0.01% 4775
2019
Q3
$487K Sell
17,550
-71,959
-80% -$1.98M ﹤0.01% 4692
2019
Q2
$2.43M Buy
89,509
+83,134
+1,304% +$2.19M ﹤0.01% 3630
2019
Q1
$167K Buy
+6,375
New +$162K ﹤0.01% 5157

Other funds holding IBDT

Morgan Stanley's IBDT Position: Q2 2026 in Review

Morgan Stanley increased its iShares iBonds Dec 2028 Term Corporate ETF (IBDT) stake by 3.6% in Q2 2026, buying an estimated $4.22M and bringing the position to 4,818,723 shares worth $122M. The position accounts for 0.01% of the portfolio, ranked #1409.

Morgan Stanley first reported a position in IBDT in Q1 2019 and has held it in 30 quarters since. 435 funds tracked by Wall St. Rank hold IBDT as of Q2 2026.

  • Morgan Stanley held 4,818,723 shares of iShares iBonds Dec 2028 Term Corporate ETF worth $122M as of Q2 2026.
  • Morgan Stanley bought 167,067 iShares iBonds Dec 2028 Term Corporate ETF shares in Q2 2026, an estimated $4.22M.
  • iShares iBonds Dec 2028 Term Corporate ETF made up 0.01% of Morgan Stanley's portfolio in Q2 2026, its #1409 holding.
  • Morgan Stanley first reported a position in iShares iBonds Dec 2028 Term Corporate ETF in Q1 2019 and has held it in 30 quarters since.
  • 435 funds tracked by Wall St. Rank held iShares iBonds Dec 2028 Term Corporate ETF as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.